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OPEN
ORIGINAL ARTICLE
Healthy obesity and risk of accelerated functional decline and
disability
JA Bell1,2, S Sabia1,3, A Singh-Manoux1,3, M Hamer4 and M Kivimäki1
BACKGROUND/OBJECTIVES: Some obese adults have a normal metabolic proﬁle and are considered ‘healthy’, but whether they
experience faster ageing than healthy normal-weight adults is unknown. We compared decline in physical function, worsening of
bodily pain and likelihood of future mobility limitation and disability between these groups.
SUBJECTS/METHODS: This was a population-based observational study using repeated measures over 2 decades
(Whitehall II cohort data). Normal-weight (body mass index (BMI) 18.5–24.9 kg m−2), overweight (25.0–29.9 kg m−2) and obese
(⩾ 30.0 kg m− 2) adults were considered metabolically healthy if they had 0 or 1 of 5 risk factors (hypertension, low high-density
lipoprotein cholesterol, high triacylglycerol, high blood glucose and insulin resistance) in 1991/1994. Decline in physical
function and worsening of bodily pain based on change in Short Form Health Survey items using eight repeated measures over
18.8 years (1991/1994–2012/2013) were compared between metabolic-BMI groups using linear mixed models. Odds of mobility
limitation based on objective walking speed (slowest tertile) and of disability based on limitations in ⩾ 1 of 6 basic activities of
daily living, each using three repeated measures over 8.3 years (2002/2004–2012/2013), were compared using logistic mixed
models.
RESULTS: In multivariable-adjusted mixed models on up to 6635 adults (initial mean age 50 years; 70% male), healthy normal-
weight adults experienced a decline in physical function of − 3.68 (95% CI =− 4.19, − 3.16) score units per decade; healthy obese
adults showed an additional − 3.48 (−4.88, − 2.08) units decline. Healthy normal-weight adults experienced a − 0.49 (−1.11, 0.12)
score unit worsening of bodily pain per decade; healthy obese adults had an additional − 2.23 (− 3.78, −0.69) units worsening.
Healthy obesity versus healthy normal-weight conferred 3.39 (2.29, 5.02) times higher odds of mobility limitation and 3.75 (1.94,
7.24) times higher odds of disability.
CONCLUSIONS: Our results suggest that obesity, even if metabolically healthy, accelerates age-related declines in functional ability
and poses a threat to independence in older age.
International Journal of Obesity advance online publication, 14 March 2017; doi:10.1038/ijo.2017.51
INTRODUCTION
Obesity is a considered a serious threat to public health.1 Health
risks of obesity are largely mediated through disruptions to
metabolism, which emerge in response to excess fat2 and which
may subsequently lead to type 2 diabetes, cardiovascular diseases
and premature mortality.3–5 As many as one-in-three obese
adults at any given time, however, present without metabolic
dysfunction in the form of metabolic risk factor clustering and
are considered ‘healthy’.6,7 This healthy subset was initially
assumed to be protected from the adverse health consequences
typical of obesity, but have since demonstrated strong tendencies
to become insulin resistant,8 to progress to unhealthy obesity9
and to develop type 2 diabetes,10 and cardiovascular disease11–13
all at greater rates than normal-weight adults who are similarly
healthy.
To our knowledge, excess risk for outcomes related to ageing
among healthy obese adults has not been examined, although
such evidence would form an important basis from which to
advise on weight loss. Obesity is strongly linked with musculos-
keletal impairments,5,14 which often manifest clinically as osteoar-
thritis of the hip or knee,15,16 one of the greatest and most
enduring sources of pain, disability and diminished quality of life
at older ages.17,18 The presence of metabolic risk factors and high
systemic inﬂammation may compound these adverse effects,19,20
but given that the primary mechanism is thought to be
mechanical strain placed on joints by excess fat,14 obesity with
or without metabolic dysfunction may be hypothesised to limit
functional ability to a similar degree. One study found that both
healthy and unhealthy obese adults showed a higher likelihood of
developing difﬁculties with walking or climbing stairs over a
7-year period than healthy normal-weight adults, suggesting
worsened physical function in response to obesity itself.21 This
ﬁnding has not been replicated and risk of other important age-
related outcomes such as bodily pain and disability have not been
compared between healthy obese and healthy normal-weight
adults.
Using repeated measures over 2 decades in a well-characterised
British cohort, the Whitehall II study, we aimed to compare long-
term changes in two key indicators of functional ability—physical
function and bodily pain—between middle-aged adults who were
initially healthy obese and healthy normal-weight. We also
compared the long-term risk of having a mobility limitation and
of being disabled between these groups in order to examine
potential for loss of independence.
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MATERIALS AND METHODS
Study population
Longitudinal data were drawn from the Whitehall II cohort study, which
recruited London-based men and women employed by the British
government in 1985/1988.22 Questionnaire data are collected every 2–3
years, and clinical data are collected every 5 years. A combination of
questionnaire data and clinical data from eight repeated assessments over
2 decades (baseline in 1991/1994; follow-up extending until 2012/2013)
were used for present analyses. The University College London research
ethics committee granted ethical approval for each phase of data
collection. Participants provided written informed consent.
Assessment of metabolic and obesity status
Data from a 1991/1994 clinical assessment were used to determine
participants’ initial obesity and metabolic status. Height and weight
were measured objectively by a nurse and used to calculate body
mass index (BMI) using the formula: weight (kg)/height (m)-squared.
On the basis of World Health Organization BMI classiﬁcations,23
participants were considered either ‘normal-weight’ (18.5–24.9 kg m−2),
‘overweight’ (25.0–29.9 kg m−2), or ‘obese’ (⩾ 30.0 kg m− 2). Participants
considered ‘underweight’ (BMI o18.5 kg m− 2) were excluded from
analyses due to their rarity (n=72, 0.87% of the sample). On the basis of
independent criteria,6 participants were also considered ‘healthy’ if they
had 0 or 1 of the following 5 metabolic risk factors: high-density lipoprotein
(HDL) cholesterol o1.03 mmol l−1 for men and o1.29 mmol l−1 for women
or use of lipid lowering medication; blood pressure ⩾ 130/85 mm Hg or
use of anti-hypertension medication; fasting plasma glucose
⩾ 5.6 mmol l− 1 or use of anti-diabetic medication; triacylglycerol⩾
1.7 mmol l− 1; homeostatic model assessment (HOMA) of insulin-
resistance (fasting glucose× fasting insulin/22.5) 43.20 (90th-percentile
value in 1991/1994).
Assessment of physical function and bodily pain
Participants were asked to answer a series of 36 question items covering
several domains of general health from the Short Form Health Survey
(SF-36) at the time of metabolic and obesity status assessment (1991/1994)
and at seven subsequent occasions (in 1995/1996, 1997/1999, 2001,
2002/2004, 2006, 2007/2009 and 2012/2013). Domains assessed by the
SF-36 have been shown to be valid measures of overall health status in the
general population24 and of change in overall health status in the
Whitehall II cohort.25
Assessment of physical function was based on a sub-domain comprised
of 10 items from the SF-36, which pertained to physical function over the
past 4 weeks. Participants reported whether they considered their health
to limit basic tasks, including vigorous activities (that is, running), moderate
activities (that is, housework), lifting or carrying groceries, climbing several
ﬂights of stairs, or movements, which involve bending, kneeling and
stooping. Response options for each item ranged from ‘not limited at all’ to
‘limited a lot’.
The assessment of bodily pain was based on another sub-domain
comprised of two items from the SF-36, which pertained to perceptions of
bodily pain during the past 4 weeks, which asked participants to report
how much bodily pain they experienced (response options ranging from
‘none’ to ‘very severe’) and how much this pain interfered with their
normal work inside and outside of the home (response options ranging
from ‘not at all’ to ‘extremely’).
Responses on each sub-domain were summed and scaled from 0 to 100
based on standard procedures for the SF-36,26 with higher scores
representing better function/less bodily pain. Summary scores for each
of physical function and bodily pain at all eight measurement occasions
were used to estimate change over time, with decreasing scores indicating
worsened physical function/bodily pain.
Assessment of mobility limitation and disability
Mobility limitation was assessed on three occasions after assessment of
metabolic and obesity status (in 2002/2004, 2007/2009 and 2012/2013). On
each occasion, participants undertook a test of walking speed based on
standard protocol,27 for which they completed a timed walk at their usual
walking pace over a distance of 8 feet while wearing low-heeled
closeﬁtting footwear or while barefoot. Timing commenced once their
foot hit the ﬂoor across the starting line, and stopped once their foot hit
the ﬂoor after the end of the walking course. The test was repeated three
times and the mean performance time of these three measurements was
used for present analyses, measured in seconds (s). On the basis of
established links with morbidity and mortality,27–30 participants were
considered to have a mobility limitation on each occasion if they were in
the slowest (versus the intermediate/fastest) tertile of walking speed.
Disability was also assessed on three occasions after assessment of
metabolic and obesity status (in 2006, 2007/2008 and 2012/2013). On each
occasion, participants reported via questionnaire whether they considered
themselves to have difﬁculty with any of 6 basic activities of daily living31
(dressing, walking across a room, bathing/showering, eating, getting in/out
of bed and using the toilet). Participants were considered ‘disabled,’ if they
reported⩾ 1 (versus 0) limitation in any activity.
Assessment of covariates
Covariates were assessed via questionnaire at the same time as metabolic
and obesity status in 1991/1994. Participant age, sex and ethnicity (‘white’
or ‘non-white’) were recorded in addition to social status based on
occupational position in the British government (‘administrative’, ‘profes-
sional/executive’, or ‘clerical/support’). Assessment of health behaviours
included cigarette smoking status (‘never smoker’, ‘ex-smoker’ or ‘current
smoker’), alcohol consumption in the previous week (‘abstainer’ based on
0 units per week, ‘moderate drinker’ based on 1–14 units per week for
women and 1–21 units per week for men, or ‘high drinker’ based on414
units per week for women and421 units per week for men), frequency of
fruit and vegetable consumption (‘less than daily or daily’, or ‘twice or
more per day’) and physical activity that was assessed by self-reported
duration (hours per week) in activities of a moderate or vigorous intensity.
Statistical analyses
Linear mixed models were used to compare mean change in physical
function and bodily pain scores over eight measurement occasions, along
with 95% conﬁdence intervals (CI), by initial metabolic and obesity status
in 1991/1994, each compared with the healthy normal-weight group.
These models minimise selection bias from missing data by using data
from all available follow-up occasions while accounting for differences in
duration of follow-up and the correlated nature of repeated measures
taken from the same individuals over time.32 Follow-up duration was used
as the time variable, divided by 10 so that regression coefﬁcients represent
effects for change over 10 years. A random intercept and a random slope
were ﬁtted to allow individual differences in initial physical function/bodily
pain score and change in these scores over time. Absolute change in each
score was also calculated for each metabolic and obesity group based on
intercept values taken at the reference groups of categorical covariates (for
men; white ethnicity; administrative/highest occupational position; never
smokers; moderate drinkers; at least twice-daily consumers of fruits and
vegetables) and age centred on the sample mean (50 years). Predictors in
the ﬁrst model included metabolic and BMI status combination (6 groups),
time, age, sex and ethnicity, each with time interactions ﬁtted where
signiﬁcant. Predictors in the second model considered those of the ﬁrst in
addition to occupational position, smoking, alcohol, fruit and vegetable
consumption, and moderate-to-vigorous physical activity, each with time
interactions where signiﬁcant.
Logistic mixed models were used to compare odds of having a mobility
limitation and of having a disability between metabolic and BMI
combination groups, each compared with healthy normal-weight. These
models minimise selection bias due to missing data for the same reasons
as mentioned for linear mixed models.32 Duration of follow-up was again
used as the time variable with time expressed per 5 years instead of per 10
years due to shortened follow-up. The same 2-stage model adjustment
strategy was otherwise applied as prior.
As some ethnic heterogeneity existed in the sample yet precise ethnic
labels were not available for ascribing ethnic-speciﬁc BMI categories,
analyses were repeated after excluding the 9% of participants who were of
a non-white ethnicity. Analyses of change in physical function and bodily
pain were also repeated after excluding those participants with only 1
available measure out of 8 on each outcome.
RESULTS
Selection and characteristics of the study population
The Whitehall II cohort originally consisted of 10 308 participants
recruited in 1985/1988.22 Of this original sample, 6641 participants
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(64.4%) had complete data on height and weight for the
assessment of BMI and on each of ﬁve metabolic risk factors of
interest as measured in the 1991/1994 clinical examination. Of
these, six participants were excluded due to missing data on each
of eight follow-up measures of physical function or bodily pain. All
remaining participants had data on basic covariates for initial
adjustments (age, sex and ethnicity). We excluded a further 392
participants from models adjusted for occupational position and
health behaviours due to missing data on these covariates.
Sample attenuation patterns were similar for outcomes of mobility
limitation and disability, with the exception of a larger reduction
(1306 participants) from the 6641 with BMI-metabolic data due to
missing data on either outcome; data collection for these began
later than for physical function and bodily pain.
Compared with participants who had metabolic-BMI data (the
initial prerequisite for inclusion) and also had data on mobility
(n= 5507), those who had metabolic-BMI data but had missing
data on mobility (n= 1134) were older (51.1 vs 49.2 years,
Po0.001), more likely to be female (34.7 vs 28.2%, Po0.001),
more likely to be of a non-white ethnicity (13.3 vs 8.5%, Po0.001)
and more likely to be of the lowest occupational position (27.1 vs
13.3%, Po0.001). Those with missing mobility data also had a
higher smoking prevalence (21.2 vs 11.8%, Po0.001) and a higher
likelihood of consuming fruit and vegetables less than daily
(46.5 vs 37.4%, Po0.001), but were no less likely to consume high
amounts of alcohol (14.1 vs 15.7%, P= 0.168) or to be less
physically active (3.4 vs 3.6 h/week, P= 0.104). Participants with
missing mobility data showed a higher prevalence of obesity
(12.6 vs 9.4%, P= 0.001) and of metabolic risk factor clustering
(39.4 vs 32.6%, Po0.001). These comparison estimates were
nearly identical among participants with vs without missing data
on disability (Supplementary Appendix).
In total, up to 6635 participants contributed data for analyses,
with the working sample size varying due to the nature of mixed
modelling. Age of participants ranged from 39 to 63 years at the
baseline assessment (mean 49.5 years) and 70.1% were men. Of
the 3339 adults who were normal-weight, 80.5% were considered
metabolically healthy; this proportion decreased with increasing
BMI group: 56.3% of 2634 overweight adults were healthy and
34.0% of 662 obese adults were healthy. Further characteristics of
participants who had complete data on metabolic and obesity
status in 1991/1994 and at least 1 measure of physical function
and bodily pain are shown in Table 1. Of those who had physical
function and bodily pain scores at baseline, those who were
healthy obese had lower (more adverse) scores than healthy
normal-weight adults, these differences being substantial at
83.3 vs 92.1 for physical function, and 77.2 vs 83.0 for pain
(both Po0.05).
Change in physical function and bodily pain
Nearly all participants (n= 6537; 98.5%) had data on at least two of
eight measures for physical function, from which to base
estimates of change (3707 participants, 55.9%, had data on all
eight measures). The interaction term between sex, metabolic-BMI
group and time in relation to physical function was not signiﬁcant
(P= 0.925), indicating similar changes in physical function by
metabolic-BMI group in both men and women. Over a mean
follow-up of 18.8 years, decline in physical function score was seen
among all metabolic and BMI combination groups over the follow-
up period (Table 2). When adjusting for basic demographic factors,
the healthy obese showed an additional − 3.42 (95% CI =− 4.80,
− 2.03) units decline per 10 years in physical function score than
healthy normal-weight adults; this difference remained after
additional adjustment for occupational position and health
behaviours (−3.48, 95% CI =− 4.88, − 2.08 units; Figure 1). This
decline was nearly two-times greater than among healthy normal-
weight adults ((3.68+3.48)/3.68 = 1.95). The greatest decline was
seen among unhealthy obese adults (additional − 5.02, 95%
CI =− 6.06, − 3.98 units) compared with healthy normal-weight
adults, but this was not signiﬁcantly greater than for healthy obese
adults (P= 0.068). Non-signiﬁcant interaction terms of time with
sex, alcohol consumption, physical activity, and fruit and
vegetable consumption were removed from these models.
Again, nearly all participants (n= 6538; 98.5%) had data on at
least two of eight measures for bodily pain, from which to base
estimates of change (3699 participants, 55.8%, had data on all
eight measures). No strong evidence for an interaction between
sex, metabolic-BMI group and time in relation to bodily pain was
observed (P= 0.054). A worsening of bodily pain score was also
seen among all metabolic and obesity groups over follow-up
Table 1. Characteristics of participants in 1991/1994 by metabolic and obesity status in the Whitehall II cohort study (n= 6635)
Healthy
normal-
weight
(n= 2688)
Unhealthy
normal-
weight
(n= 651)
Healthy
overweight
(n=1482)
Unhealthy
overweight
(n= 1152)
Healthy
obese
(n= 225)
Unhealthy
obese
(n=437)
Female—n (%) 863 (32.1) 89 (13.7)a 481 (32.5) 193 (16.8)a 148 (65.8)a 172 (39.4)a
Age, years—mean (s.d.) 48.7 (6.0) 50.2 (6.0)a 49.5 (5.9)a 50.8 (6.0)a 49.7 (5.8)a 50.3 (5.9)a
Non-white ethnicity—n (%) 185 (6.9) 78 (12.0)a 139 (9.4)a 126 (10.9)a 42 (18.7)a 48 (11.0)a
Lowest occupational position—n (%) 357 (13.3) 73 (11.2) 268 (18.1)a 168 (14.7) 64 (28.7)a 104 (24.1)a
Consumes fruit and vegetablesodaily—n (%) 947 (35.2) 264 (40.6)a 584 (39.4)a 512 (44.4)a 77 (34.2) 198 (45.3)a
Current smoker—n (%) 320 (12.6) 93 (14.9) 183 (13.2) 154 (14.2) 31 (14.6) 56 (13.7)
High alcohol consumption in previous week—n (%) 353 (13.2) 111 (17.1)a 236 (16.0)a 222 (19.4)a 31 (14.0) 68 (15.8)
Moderate-to-vigorous physical activity, h per week—mean (s.d.) 3.7 (4.1) 3.5 (3.9) 3.6 (4.2) 3.6 (4.0) 2.7 (3.1)a 2.7 (3.2)a
Systolic blood pressure, mm Hg—mean (s.d.) 115.9 (12.0) 127.5 (14.6)a 118.7 (11.2)a 128.0 (13.0)a 121.0 (13.5)a 130.6 (12.7)a
Diastolic blood pressure, mm Hg—mean (s.d.) 76.2 (8.4) 83.8 (8.9)a 79.0 (8.1)a 85.6 (8.6)a 80.6 (9.4)a 87.1 (8.9)a
Fasting glucose, mmol l− 1—mean (s.d.) 5.1 (0.4) 5.6 (0.9)a 5.1 (0.4) 5.6 (0.8)a 5.0 (0.4) 5.7 (1.3)a
HOMA insulin resistance—mean (s.d.) 1.0 (0.8) 1.8 (1.3)a 1.4 (0.8)a 2.5 (2.1)a 1.7 (1.0)a 4.1 (4.5)a
Triacylglycerol, mmol l− 1—mean (s.d.) 1.0 (0.4) 2.0 (1.2)a 1.2 (0.5)a 2.2 (1.2)a 1.2 (0.5)a 2.3 (1.2)a
HDL cholesterol, mmol l− 1—mean (s.d.) 1.6 (0.4) 1.2 (0.4)a 1.5 (0.3)a 1.2 (0.3)a 1.5 (0.3)a 1.2 (0.3)a
Body mass index, kg m−2—mean (s.d.) 22.6 (1.6) 23.4 (1.3)a 26.7 (1.3)a 27.2 (1.4)a 32.4 (2.5)a 33.4 (3.4)a
Initial physical function scoreb—mean (s.d.) 92.1 (12.1) 90.9 (13.1) 89.6 (14.6)a 89.0 (14.1)a 83.3 (17.9)a 81.5 (18.4)a
Initial bodily pain scoreb—mean (s.d.) 83.0 (19.0) 83.3 (18.5) 81.2 (20.2)a 82.4 (19.4) 77.2 (21.8)a 77.5 (22.5)a
Participants described are those with the data on metabolic and obesity status and at least one measurement of physical function and bodily pain. aDifferent
from healthy normal-weight (Po0.05). bOn the basis of participants with a physical function and pain score in 1991/94.
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(Table 2). This worsening was greater among healthy obese
compared with healthy normal-weight adults when considering
basic demographics (difference in 10-year change =− 2.15, 95%
CI =− 3.66, − 0.63 units); this difference remained after additional
adjustment for social and behavioural factors (−2.23, 95%
CI =− 3.78, − 0.69 units; Figure 1), equating to nearly a six-times
greater worsening than that of healthy normal-weight adults
((0.49+2.23))/0.49 = 5.55). The greatest worsening was seen among
unhealthy obese adults (difference in 10-year change =− 4.10,
95% CI =− 5.24, − 2.95 compared with healthy normal-weight);
there was weak evidence of this being greater than for the healthy
obese (P= 0.045). A non-signiﬁcant interaction term of time with
physical activity was removed from these models.
Odds of mobility limitation and disability
Among 6641 participants whose metabolic and BMI status was
assessed in 1991/1994, up to 5507 (82.9%) had at least one
assessment of mobility limitation over a mean observation period
of 8.3 years (3841 participants (57.8%) had all three assessments).
The proportion of adults who had a mobility limitation over
follow-up was lowest among healthy normal-weight adults at
29.1%, and highest among healthy obese and unhealthy obese
adults, at 60.1 and 56.7%, respectively. Differences in odds of
mobility limitation by metabolic and obesity group did not differ
over follow-up (p for interaction of metabolic and BMI combina-
tion with time= 0.36) and so this time interaction was removed;
likewise for sex and ethnicity (P-values for interaction with
time= 0.099 and 0.175, respectively). Compared with healthy
normal-weight adults, healthy obese adults showed 3.92 (95%
CI = 2.64, 5.80) times higher odds of having a mobility limitation
over follow-up when adjusting for demographics; odds remained
3.39 (95% CI = 2.29, 5.02) times higher when additionally adjusting
for social and behavioural factors (Figure 2; Table 3). Raised odds
of mobility limitation were highest among unhealthy obese adults
at 4.01 (95% CI = 2.98, 5.40) times higher than healthy normal-
weight adults, however, this was not signiﬁcantly higher than the
healthy obese (P= 0.48).
Among 6641 participants whose metabolic and BMI status was
assessed in 1991/1994, up to 5616 (84.6%) had at least one
assessment of disability over a mean observation period of 5.6
years (4434 participants (66.8%) had all three assessments). The
proportion of adults who had a disability over follow-up was
lowest among healthy normal-weight adults at 9.1%, and
progressively higher among healthy obese and unhealthy obese
adults at 18.6 and 27.0%, respectively. Again, a non-signiﬁcant
interaction of metabolic and BMI combination with time (P= 0.34)
provided no evidence that differences in odds of disability by
metabolic and obesity group changed over follow-up, this time
interaction was therefore removed; likewise for all other covariates
except for age, which reached signiﬁcance (P-value for interaction
with time o0.001). Compared with healthy normal-weight adults,
healthy obese adults were 3.84 (95% CI = 2.01, 7.34) times more
likely to be disabled when adjusting for basic demographic
factors; these odds remaining elevated at 3.75 (95% CI = 1.94, 7.24)
times higher when additionally adjusting for social and beha-
vioural factors (Figure 2; Table 3). The highest raised odds were
seen among unhealthy obese adults (OR = 8.37, 95% CI = 5.25,
13.35 vs healthy normal-weight), there was some evidence of this
being higher than for healthy obese adults (P= 0.03).
Sensitivity analyses
Results of sensitivity analyses are provided in Supplementary
Appendix. Results of analyses that excluded the 9% of participants
who were of a non-white ethnicity were largely unchanged; as
Table 2. Decline in physical function and worsening of bodily pain
per decade by initial metabolic and obesity status in the Whitehall II
cohort study
Model 1 Model 2
B (95% CI) B (95% CI)
Decline in physical function per 10 yearsa
Decline in healthy normal-weight − 4.27 (−4.68, − 3.86) − 3.68 (−4.19, − 3.16)
Healthy normal-weight (n= 2569) 0.00 (reference) 0.00 (reference)
Unhealthy normal-weight (n= 615) − 0.74 (−1.60, 0.12) − 0.61 (−1.47, 0.26)
Healthy overweight (n= 1420) − 0.68 (−1.30, − 0.06) − 0.54 (−1.18, 0.09)
Unhealthy overweight (n= 1070) − 1.48 (−2.17, − 0.78) − 1.22 (−1.92, − 0.52)
Healthy obese (n= 205) − 3.42 (−4.80, − 2.03) − 3.48 (−4.88, − 2.08)
Unhealthy obese (n= 401) − 5.18 (−6.20, − 4.17) − 5.02 (−6.06, − 3.98)
Worsening of bodily pain per 10 yearsa
Worsening in healthy normal-weight − 1.15 (−1.60, − 0.71) − 0.49 (−1.11, 0.12)
Healthy normal-weight (n= 2560) 0.00 (reference) 0.00 (reference)
Unhealthy normal-weight (n= 616) − 0.54 (−1.48, 0.39) − 0.36 (−1.31, 0.60)
Healthy overweight (n= 1412) − 1.23 (−1.91, − 0.56) − 1.10 (−1.80, − 0.41)
Unhealthy overweight (n= 1070) − 1.55 (−2.30, − 0.79) − 1.31 (−2.09, − 0.53)
Healthy obese (n= 208) − 2.15 (−3.66, − 0.63) − 2.23 (−3.78, − 0.69)
Unhealthy obese (n= 403) − 4.35 (−5.46, − 3.24) − 4.10 (−5.24, − 2.95)
Model 1 adjusted for age, sex and ethnicity in 1991/1994. Model 2
additionally adjusted for occupational position, moderate-to-vigorous
physical activity, smoking, alcohol, and fruit and vegetable consumption
in 1991/1994. Reference group for intercept is men in these analyses;
interaction terms with sex were non-signiﬁcant and ﬁndings were
similar when analyses were repeated with women as the reference
(Supplementary Appendix). aLower scores indicate worsened function/
pain.
Figure 1. Decline in physical function (a) and worsening of bodily
pain (b) over 2 decades by initial metabolic and obesity status.
Models include adjustment for 1991/1994 values of age, sex,
ethnicity, occupational position, moderate-to-vigorous physical
activity, smoking, alcohol, and fruit and vegetable consumption.
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were results of analyses of change in physical function and bodily
pain that excluded participants with only 1 measurement of each
outcome. A larger participant drop-out was observed for mobility
limitation and disability than for physical function and bodily pain;
a comparison of characteristics between included versus excluded
participants for these former outcomes is given in Supplementary
Appendix.
DISCUSSION
This study of 6635 men and women examined whether obese
adults who are metabolically healthy experience faster ageing
than normal-weight adults who are similarly healthy by way of
greater declines in physical function, greater worsening of bodily
pain, and higher likelihoods of having a mobility limitation and
disability in older age. Our results showed that over the course of
2 decades, decline in physical function and worsening of bodily
pain among initially healthy obese adults was two- and six-times
greater than among initially healthy normal-weight adults,
respectively. These changes occurred at similar rates for both
healthy and unhealthy obese adults. A comparably higher
likelihood of having a mobility limitation and of being disabled
was also observed. This suggests that obesity, even if metaboli-
cally healthy, accelerates age-related declines in functional ability
and poses a threat to independence in older age.
Comparisons of walking speed between healthy obese and
healthy normal-weight groups is novel; only 1 previous study of
women found that the healthy obese performed better than the
unhealthy obese on a timed test of walking distance, but
comparisons were not made with the healthy normal-weight.33
That study was also limited by a small sample size (total n= 86)
and a single measurement occasion; the present study considered
three measurement occasions of walking speed spanning nearly a
decade to provide a better estimate of usual walking capacity.
The likelihood of being disabled was somewhat lower among
healthy obese than among unhealthy obese adults, but the
difference between these two groups was small and not likely
signiﬁcant in terms of disability burden. Indeed, healthy obese
adults are known to have a strong tendency to progress to an
unhealthy obese state; this proportion is about one-half in the
Whitehall II cohort after 20 years.9 Importantly, these progressions
to unhealthy obesity occur at greater rates among adults who are
initially healthy obese than among adults who are either healthy
or unhealthy non-obese, likely reﬂecting causal effects of higher
BMI on metabolic dysfunction and of higher BMI on lower physical
activity as supported by Mendelian randomisation studies.23,34,35
Similar to previous studies, healthy obesity was deﬁned here
using an array of metabolic risk factors that are commonly
measured in clinical settings, and such classiﬁcations based on the
binary presence or absence of blood-based risk factors using cut-
points may offer clinical relevance at the expense of scientiﬁc
precision. Indeed, descriptive characteristics of participants at ﬁrst
measurement showed that healthy obese adults had more
adverse levels of most metabolic risk factors than healthy
normal-weight adults despite both groups being classiﬁed as
‘healthy’; this is commonly observed across studies in this area. We
did not analyse the already established associations of healthy
obesity with metabolic decline,9 type 2 diabetes,10 cardiovascular
disease13 or other chronic diseases36 as these are expected to
mediate and not confound associations with functional outcomes.
We considered only those activities of daily living which were
considered basic and not instrumental in assessing disability
because basic activities are thought to be more closely related to
functional status and are more severe and limiting, whereas
instrumental activities such as one’s ability to manage money
often relate more to cognitive functioning and can more readily
be adapted to with informal caregiving.
Figure 2. Likelihood of having a mobility limitation (a) and of having
a disability (b) over 8.3 years by initial metabolic and obesity status.
Models include adjustment for 1991/1994 values of age, sex,
ethnicity, occupational position, moderate-to-vigorous physical
activity, smoking, alcohol, and fruit and vegetable consumption.
Table 3. Odds of mobility limitation and disability among adults over
8.3 years by initial metabolic and obesity status in the Whitehall II
cohort study
Model 1 Model 2
Odds ratio (95% CI) Odds ratio (95% CI)
Odds of having a mobility limitationa
Healthy normal-weight (n= 2023) 1.00 (reference) 1.00 (reference)
Unhealthy normal-weight (n= 448) 1.22 (0.95, 1.56) 1.13 (0.88, 1.45)
Healthy overweight (n= 1101) 1.44 (1.21, 1.71) 1.31 (1.10, 1.56)
Unhealthy overweight (n= 812) 1.85 (1.52, 2.25) 1.57 (1.28, 1.91)
Healthy obese (n= 148) 3.92 (2.64, 5.80) 3.39 (2.29, 5.02)
Unhealthy obese (n= 275) 4.58 (3.41, 6.13) 4.01 (2.98, 5.40)
Odds of having a disabilityb
Healthy normal-weight (n= 2250) 1.00 (reference) 1.00 (reference)
Unhealthy normal-weight (n= 502) 0.83 (0.51, 1.33) 0.77 (0.47, 1.25)
Healthy overweight (n= 1208) 1.72 (1.25, 2.36) 1.70 (1.22, 2.36)
Unhealthy overweight (n= 901) 2.22 (1.57, 3.14) 2.13 (1.49, 3.04)
Healthy obese (n= 161) 3.84 (2.01, 7.34) 3.75 (1.94, 7.24)
Unhealthy obese (n= 333) 8.89 (5.64, 14.00) 8.37 (5.25, 13.35)
Model 1 adjusted for age, sex and ethnicity in 1991/1994. Model 2
additionally adjusted for occupational position, moderate-to-vigorous
physical activity, smoking, alcohol, and fruit and vegetable consumption
in 1991/1994. aMobility limitation deﬁned as being in the slowest vs
fastest/intermediate tertile of walking speed. bDisabled deﬁned as
having⩾1 out of 6 limitations in basic activities of daily living.
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Strengths and limitations
Change in two key indicators of functional status were examined
utilising up to 8 repeated measures over a follow-up period
spanning 2 decades, providing a more comprehensive view of
long-term change than previously possible. Mixed modelling was
performed to make maximum use of all available data over the
long follow-up period and to minimise the effects that selection
bias due to missing data can have on results. The extent of
missing data was largest for mobility and disability outcomes, with
participants missing on these outcomes appearing more socio-
economically disadvantaged and less behaviourally and physically
healthy than those with complete data; however, the impact of
this selection bias is expected to be more modest here given the
use of repeated measures on outcomes compared to what would
be expected if a more restrictive sample was used for complete
case analyses. The indicators of physical function and bodily pain
used were also based on self-reported questionnaire items which
are subject to biases in reporting and individual subjectivity;
however, both objective and self-reported measures were used to
assess functional limitations in the form of mobility limitation and
disability, allowing for internal validation of self-reported ﬁndings
and improved consistency of results.
CONCLUSIONS
Our results suggest that obesity, even if metabolically healthy,
accelerates age-related declines in functional ability and poses a
threat to independence in older age. Long-term decline in
physical function was nearly two-times greater, and worsening
of bodily pain nearly six-times greater, among obese adults who
are metabolically healthy than among normal-weight adults who
are similarly healthy. The likelihood of developing a mobility
limitation and of becoming disabled was also nearly four-times
greater among healthy obese than among healthy normal-
weight adults. Weight loss is therefore still advisable for healthy
obese adults for the purpose of preserving the quality of
later life.
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